Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
842K
-
Shares change
-
-1.59K
-
Total reported value, excl. options
-
$123M
-
Value change
-
-$596K
-
Number of buys
-
23
-
Number of sells
-
-54
-
Price
-
$145.79
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2022
124 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2022.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 842K shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (106K shares), JPMORGAN CHASE & CO (77.4K shares), MORGAN STANLEY (75K shares), BANK OF AMERICA CORP /DE/ (66.3K shares), LPL Financial LLC (42.7K shares), ROYAL BANK OF CANADA (37K shares), UBS Group AG (37K shares), MOGY JOEL R INVESTMENT COUNSEL INC (35.1K shares), MURPHY CAPITAL MANAGEMENT INC (30.1K shares), and Conservest Capital Advisors, Inc. (23.1K shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.